Clinical trial
A Randomized, Double-blind, Placebo-controlled, Multi-center II Clinical Trial to Evaluate the Efficacy and Safety of Wei Li Bai Capsules in the Treatment of Mild to Moderate Alzheimer's Disease
NCT05670912 is registered in ClinicalTrials.gov with Capital Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Double-blind, Placebo-controlled, Multi-center II Clinical Trial to Evaluate the Efficacy and Safety of Wei Li Bai Capsules in the Treatment of Mild to Moderate Alzheimer's Disease
- Lead sponsor
- Capital Medical University
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- October 1, 2022
- Completion date
- November 12, 2024
- Enrollment
- 105 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.